Retrospective and Prospective Observational Study of MRI Changes in Bone and Visceral Lesions of Patients With Type 1 Gaucher Disease Treated With VPRIV® (Velaglucerase Alfa)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 17, 2017

Primary Completion Date

September 13, 2017

Study Completion Date

December 27, 2018

Conditions

Gaucher Disease, Type 1MRI

Interventions

OTHER

MRI

Trial Locations (1)

Beaujon Hospital, Clichy